MENU
Aim higher

META-DETECT

Identifying patients at risk of relapse of (metastatic) colorectal cancer with targeted imaging

META-DETECT will develop a multi-target imaging agent to diagnose, stage and determine the risk of relapse in colorectal cancer (CRC). The novel imaging agent will combine llama VHH antibody fragments with a nanoparticle that can be visualized with numerous imaging instruments rendering an unparalleled sensitivity and specificity. It will be able to accurately localize and characterize tumours, and predict the risk for CRC relapse, which will significantly improve the chance of survival.
Project ID: 
10 610
Ranking: 
30
Cut-off: 
5
Start date: 
01-10-2016
Project Duration: 
36months
Project costs: 
2 113 950.00€
Technological Area: 
Medical devices technology (instrumentation, medical imaging, radiology)
Market Area: 
Medical imaging